NasdaqGS - Delayed Quote USD
Stoke Therapeutics, Inc. (STOK)
11.53
-0.29
(-2.45%)
At close: 4:00:00 PM EDT
11.53
0.00
(0.00%)
After hours: 4:04:14 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| ALLAN JONATHAN General Counsel | Sale | Mar 19, 2025 | 31,565 |
| KAYE EDWARD M Director | Sale | Mar 19, 2025 | 139,346 |
| LEVIN ARTHUR A. Director | Conversion of Exercise of derivative security | Mar 31, 2025 | 19,189 |
| NASH HUW MICHAEL Officer | Sale | Jul 2, 2024 | 0 |
| SKORPIOS TRUST Trustee | Sale | Jun 4, 2025 | -- |
| TICHO BARUCH S Officer | Sale | Jun 3, 2025 | 25,782 |
| TULIPANO STEPHEN J Chief Financial Officer | Sale | Mar 19, 2024 | 20,746 |
| TZIANABOS ARTHUR Director | Conversion of Exercise of derivative security | Feb 13, 2024 | 31,739 |
Related Tickers
YMAB Y-mAbs Therapeutics, Inc.
4.7100
+1.73%
REPL Replimune Group, Inc.
9.78
-1.06%
ORIC ORIC Pharmaceuticals, Inc.
9.63
-0.41%
ALEC Alector, Inc.
1.5400
-4.94%
SRRK Scholar Rock Holding Corporation
32.45
-2.61%
AKRO Akero Therapeutics, Inc.
55.62
+3.85%
ETNB 89bio, Inc.
10.41
+8.21%
GOSS Gossamer Bio, Inc.
1.2400
-2.36%
CRNX Crinetics Pharmaceuticals, Inc.
31.77
-1.24%
TYRA Tyra Biosciences, Inc.
10.43
+0.97%